Roivant Sciences Ltd. (ROIV) Tops Q4 EPS by 57c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q4 EPS of $0.28, $0.57 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $2.52 million versus the consensus estimate of $3.76 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Apple investigating exposure to Tata Electronics data breach, full analysis underway - Reuters
• Buy gold stocks as valuations are cheap amid macro tension: BofA